Earlier this year, Canada became the first major market in the world where generic forms of semaglutide became legal. The competition was on: Manufacturers raced to secure Health Canada approval so ...

Bluetooth dual device connectivity, aka "multipoint," isn't an official feature or spec. It's an application of Bluetooth technologies, and each manufacturer wields it differently. Further migration ...

Telehealth provider Hims & Hers Health Inc. announced Thursday the availability of generic semaglutide through its platform, allowing eligible Canadians access to digital prescriptions for the popular ...

But health economists and pharmacists say the site works best for a narrow group of people — those without insurance, or anyone on a high-deductible plan looking for deals on brand-name drugs with no ...

The Trump administration on Monday said it is adding generic medications to its direct-to-consumer drug sales website, TrumpRx. The platform, which launched in February, is key to his administration's ...

President Trump announced the addition of 600 medicines to his online drugstore as he appeals to Americans concerned about high drug prices and affordability. By Rebecca Robbins President Trump said ...

India got it earlier this year, and Canada approved it last month. But when is the United States going to get a generic version of Ozempic? Subscribe to read this story ad-free Get unlimited access to ...

The software industry is racing to write code with artificial intelligence. It is struggling, badly, to make sure that code holds up once it ships. A survey of 200 senior site-reliability and DevOps ...

Commentary: The AirFly Pro lets you connect wirelessly to in-flight entertainment, making it a handy sidekick for your next trip. Kimanzi Constable is a CNET Perspectives contributor who writes about ...

One of the world’s leading healthcare names, Novo Nordisk (NYSE:NVO | NVO Price Prediction) cut prices on Wegovy and Ozempic by up to 48% in India at the start of April 2026, a direct response to ...

One of the world's leading healthcare names, Novo Nordisk (NYSE:NVO) cut prices on Wegovy and Ozempic by up to 48% in India at the start of April 2026, a direct response to low-cost generic ...